In May of this year, FDA approved a new drug for smoking cessation: varenicline, a nicotinic acetylcholine receptor partial agonist, which presumably reduces craving and abstinence symptoms. Three studies sponsored by pharmaceutical industry were performed. In the first study, 1025 smokers (18-75 [...]